1st Circuit Revives Investors’ Suit Claiming Falsehoods About Alzheimer’s Drug
BOSTON — A panel of the First Circuit U.S. Court of Appeals partly reversed a federal judge’s dismissal of a complaint brought by a group of investors who claimed that a...To view the full article, register now.
Already a subscriber? Click here to view full article